Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
about
Duchenne Muscular Dystrophy: From Diagnosis to TherapyDystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophiesAnti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factorsIn vitro stability of therapeutically relevant, internally truncated dystrophins.piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.2'-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 Skipping.Efficient Skipping of Single Exon Duplications in DMD Patient-Derived Cell Lines Using an Antisense Oligonucleotide Approach.Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.Effective regeneration of dystrophic muscle using autologous iPSC-derived progenitors with CRISPR-Cas9 mediated precise correction.Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy.Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletions.Skipping Multiple Exons to Treat DMD-Promises and Challenges.
P2860
Q26784259-B0448522-1370-465A-9FCE-B6E3EBEC4FF5Q26795772-1A4C3BCC-C145-4966-B920-A0AE93C62359Q28069464-F011BDCD-EA7E-4A7F-9632-4B0478827D1FQ35582583-350FBCC4-7498-46E1-B02B-CCBD1B3395CCQ36532676-07ABF084-B07D-4E1A-A0D9-FB9BB2445774Q39139178-A3AB6A89-DBC2-4D18-8AAA-A99FEA767750Q45871516-C5362D59-8AAA-4E39-88B4-CDD07A1ACA3EQ45874288-383532C3-F2C9-4A32-B830-E20D96E7F833Q47216392-ED55CC6A-04A2-4D1D-A675-A5080741EDCFQ51264255-21E93A3D-B51D-453C-8019-FAB52DF7261EQ52357025-6F8D0CF6-9BC2-4E18-AD87-6D78EE7D29A2Q52429827-C78700B6-AD57-4D55-8B6D-F6C4E697E471
P2860
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
@ast
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
@en
type
label
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
@ast
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
@en
prefLabel
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
@ast
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.
@en
P2093
P2860
P50
P356
P1433
P1476
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45
@en
P2093
Alan Pestronk
Andrew R Findlay
Diane M Dunn
Elisabeth Le Rumeur
Jerry R Mendell
John W Day
Julaine M Florence
Laura E Taylor
Michael T Howard
Nicolas Wein
P2860
P304
P356
10.1002/ANA.24365
P577
2015-03-02T00:00:00Z